Figure 2From: Investigation of the factors associated with circulating soluble CD36 levels in patients with HCV-related chronic liver diseaseRepresentative figures of dual staining with anti-CD14 and anti-CD36 in the liver specimens. (a) immunohistochemical staining with anti-CD36 (b) immunohistochemical staining with anti-CD14, (c) nuclear staining with DAPI, (d) dual staining of anti-CD14 with anti-CD36 (original magnification × 100).Back to article page